Gene Biotherapeutics, Inc. Stock Agreements
3 Contracts & Agreements
- Preferred Stock Purchase Agreement dated May 22, 2020 for the purchase of Series B Convertible Preferred Stock (Filed With SEC on May 28, 2020)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 4, 2014)
- CARDIUM THERAPEUTICS, INC. DOCSĀ® financing facility Shares of Common Stock, $0.0001 par value SALES AGREEMENT September 28, 2010 (Filed With SEC on September 29, 2010)